Kohl’s Corp. has rejected the advice of activist investors and buy-out offers, adopted a poison pill and squared off against the firm leading the effort to reconstitute the company, Macellum Advisors. The Kohl’s board of directors has issued a statement...
Kohl’s Corp. is in demand as bidders and investors clamor to change the shape of the company. Kohl’s has issued a short statement saying it “confirmed that it has received letters expressing interest in acquiring the company. The Kohl’s board of directors will...
